Switzerland · Delayed Price · Currency is CHF Newron Pharmaceuticals Statistics
Total Valuation
SWX:NWRN has a market cap or net worth of CHF 173.73 million. The enterprise value is 179.41 million.
| Market Cap | 173.73M |
| Enterprise Value | 179.41M |
Important Dates
The last earnings date was Tuesday, September 22, 2026.
| Earnings Date | Sep 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SWX:NWRN has 21.24 million shares outstanding. The number of shares has decreased by -4.83% in one year.
| Current Share Class | 21.24M |
| Shares Outstanding | 21.24M |
| Shares Change (YoY) | -4.83% |
| Shares Change (QoQ) | +2.81% |
| Owned by Insiders (%) | 9.32% |
| Owned by Institutions (%) | 6.00% |
| Float | 19.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.07 |
| PB Ratio | -16.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.15
| Current Ratio | 3.15 |
| Quick Ratio | 2.89 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.31 |
| Interest Coverage | -5.95 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -27.83% |
| Return on Invested Capital (ROIC) | -81.54% |
| Return on Capital Employed (ROCE) | -81.54% |
| Weighted Average Cost of Capital (WACC) | 8.19% |
| Revenue Per Employee | 356,150 |
| Profits Per Employee | -1.01M |
| Employee Count | 27 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SWX:NWRN has paid 808,646 in taxes.
| Income Tax | 808,646 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.47% in the last 52 weeks. The beta is 0.73, so SWX:NWRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -27.47% |
| 50-Day Moving Average | 11.49 |
| 200-Day Moving Average | 15.43 |
| Relative Strength Index (RSI) | 24.99 |
| Average Volume (20 Days) | 101,211 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:NWRN had revenue of CHF 9.62 million and -27.27 million in losses. Loss per share was -1.35.
| Revenue | 9.62M |
| Gross Profit | 9.62M |
| Operating Income | -20.90M |
| Pretax Income | -26.46M |
| Net Income | -27.27M |
| EBITDA | -20.88M |
| EBIT | -20.90M |
| Loss Per Share | -1.35 |
Balance Sheet
The company has 30.36 million in cash and 36.03 million in debt, with a net cash position of -5.67 million or -0.27 per share.
| Cash & Cash Equivalents | 30.36M |
| Total Debt | 36.03M |
| Net Cash | -5.67M |
| Net Cash Per Share | -0.27 |
| Equity (Book Value) | -10.78M |
| Book Value Per Share | -0.52 |
| Working Capital | 24.89M |
Cash Flow
In the last 12 months, operating cash flow was -10.86 million and capital expenditures -34,155, giving a free cash flow of -10.90 million.
| Operating Cash Flow | -10.86M |
| Capital Expenditures | -34,155 |
| Depreciation & Amortization | 21,358 |
| Net Borrowing | -12.80M |
| Free Cash Flow | -10.90M |
| FCF Per Share | -0.51 |
Margins
Gross margin is 100.00%, with operating and profit margins of -217.36% and -283.56%.
| Gross Margin | 100.00% |
| Operating Margin | -217.36% |
| Pretax Margin | -275.15% |
| Profit Margin | -283.56% |
| EBITDA Margin | -217.14% |
| EBIT Margin | -217.36% |
| FCF Margin | n/a |
Dividends & Yields
SWX:NWRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 4.83% |
| Shareholder Yield | 4.83% |
| Earnings Yield | -15.69% |
| FCF Yield | -6.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for SWX:NWRN is 47.87, which is 499.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 47.87 |
| Price Target Difference | 499.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 84.44% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SWX:NWRN has an Altman Z-Score of 2.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 2 |